Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
09/2005
09/09/2005WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist
09/09/2005WO2005065164A3 Process for preparing fluorochemical monoisocyanates
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939646 Polymer electrolyte and process for producing the same
09/01/2005WO2005080324A1 Sulfonamide derivatives for the treatment of diseases
09/01/2005WO2005080323A1 Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide
09/01/2005WO2005080313A2 Sulfonamide derivatives for the treatment of diseases
09/01/2005WO2005079270A2 2-substituted and 4-substituted aryl nitrone compouds
09/01/2005WO2005063665B1 Propofol analogs, process for their preparation, and methods of use
09/01/2005US20050192317 Novel diamines having a casr modulating activity
09/01/2005CA2560347A1 Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide
09/01/2005CA2556270A1 2-substituted and 4-substituted aryl nitrone compouds
08/2005
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568687A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use
08/31/2005EP1567485A1 Perfluoroalkyle sulphonamide salts and their use as complexing agents
08/31/2005EP1567141A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases
08/31/2005EP1483276B1 Ferrocenyl ligands and the use thereof in catalysis
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662489A N-sulphonylaminoacetonitriles having pesticidal properties
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1660798A Processes for preparing aminophenylsulfonylureas, and intermediates therefor
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/25/2005WO2005078741A1 Mixture, cation conductor and electrochemical device using those
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077884A2 Hydroaminomethylation of olefins
08/25/2005WO2005077122A2 Compounds and compositions as lxr modulators
08/25/2005WO2005049590A3 N-sulfonylaminocarbonyl containing compounds
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187246 Cell proliferation inhibitors
08/25/2005US20050186198 Serine protease inhibitors
08/25/2005CA2553442A1 Compounds and compositions as lxr modulators
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565438A1 Antitumor benzoylsulfonamides
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659154A Method of preparing amine stereoisomers
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/23/2005US6933319 Resorcinol derivatives
08/18/2005WO2005075973A2 Acousto-mechanical detection systems and methods of use
08/18/2005WO2005075416A1 Amorphous tamsulosin hydrochloride
08/18/2005WO2005075415A1 A method of preparation of (r)-(-)-5(2-aminopropyl)-2-methoxybenzenesulfonamide
08/18/2005WO2005075073A1 Water-soluble transition metal-diamine complex and use thereof
08/18/2005US20050182091 For therapy of asthma or chronic obstructive pulmonary disease (COPD) in a mammal
08/18/2005US20050182060 2-Substituted and 4-substituted aryl nitrone compounds
08/18/2005DE102004004928A1 Dibenzoxazepine II Dibenzoxazepines II
08/18/2005CA2554851A1 A method of preparation of (r)-(-)-5(2-aminopropyl)-2-methoxybenzenesulfonamide
08/18/2005CA2551957A1 Acousto-mechanical detection systems and methods of use
08/17/2005EP1562897A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1232143B1 Method for preparing dimetal sulfonyl amide salts
08/17/2005CN1656063A Heat sensitive recording material
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6929685 Alkylamine derivatives as antifouling agents
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005072741A1 ((11-oxo-10,11-dihydrodibenzo [b, f] [1, 4] oxazepin-1-yl)oxy) acetic acid derivatives and related compounds as cardiovascular preparations used to treat arteriolosclerosis
08/11/2005WO2005054174A3 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
08/11/2005WO2005051914A8 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/11/2005WO2005051898A3 Vitamin d receptor modulators
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176994 Simultaneously or continuously reacting a sulfuric ester alkylating agent, an aromatic hydrocarbon preferably containing an electron withdrawing group and an electron donating group, and a maleic anhydride derivative.
08/11/2005US20050176993 Urokinase inhibitors, production and use thereof
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050176821 Meta-substituted phenylene sulphonamide derivatives
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050175867 Room-temperature molten salt, process for producing the same and applications thereof
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653030A Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1214003C Water-and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
08/10/2005CN1213990C Process for purification of substd. p-nitrodiphenylethers
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/04/2005WO2005070883A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 177